Chartwell Pharmaceuticals

Chartwell Pharmaceuticals is a US-based, full-service manufacturing, packaging, laboratory, and related supply chain services organization with multiple manufacturing locations in Congers, Carmel and Amityville, New York. The highest quality prescription pharmaceutical products have been produced in our cGMP compliant facilities for over 25 years. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing, research & development and analytical services. Our expertise includes developing, transferring, optimizing, and reliable manufacturing of trusted quality products. As a result of our corporate development strategy, our significant plant expansions and acquisitions and investment in new dosage forms and technologies, Chartwell continues to grow our business and broaden our technical and service offerings. We can readily meet the demands of our clients and partners throughout the product life cycle, from API characterization through formulation trials, clinical supplies and full-scale commercial batches. With over 1,100 Orange Book listings and growing, Chartwell is now the 5th largest US generic pharmaceutical manufacturer in terms of ANDA holdings. Our ~700 commercialized NDCs include a recent expansion into Unit Dose Liquids and a soon-to-launch Semi-Solids portfolio. Chartwell Pharmaceuticals products meet the qualifications and growing demand for both Trade Act Agreement (TAA) and Buy American Act (BAA) compliant products. We are proud to be manufacturing products in the US for our global clients and partners.